PA
GEF icon

PharVision Advisers’s Greif GEF Stock Holding History

PharVision Advisers’s Portfolio GEF Stock Details GEF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,482
Closed -$291K – 710
2025
Q2 		$291K Buy
+4,482
New +$255K 0.42% 87
2025
Q1 		– Sell
-3,391
Closed -$207K – 363
2024
Q4 		$207K Buy
+3,391
New +$221K 0.18% 288

Other funds holding GEF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PharVision Advisers's GEF Position: Q3 2025 in Review

PharVision Advisers sold out of Greif (GEF) in Q3 2025, closing a stake of 4,482 shares — an estimated $291K sold.

PharVision Advisers first reported a position in GEF in Q4 2024 and held it in 2 quarters. The position peaked at $291K in Q2 2025. 267 funds tracked by Wall St. Rank hold GEF as of Q3 2025.

  • PharVision Advisers reported no remaining Greif position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 4,482 Greif shares in Q3 2025, an estimated $291K.
  • PharVision Advisers first reported a position in Greif in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Greif position peaked at $291K in Q2 2025.
  • 267 funds tracked by Wall St. Rank held Greif as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.